Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
Melanoma is a lethal form of skin cancer. Immunotherapeutic agents such as anti-PD-1 (pembrolizumab and nivolumab) and anti-CTLA-4 (ipilimumab) have revolutionized melanoma treatment; however, drug resistance is rapidly acquired. Several studies have reported an increase in melanoma rates in older p...
Main Authors: | Nehal Farid El-Helbawy, Ahmed Ezat El Zowalaty |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/44/9/282 |
Similar Items
-
Monoallelic expression in melanoma
by: Lee Silcock, et al.
Published: (2019-04-01) -
Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
by: Fernanda Costa Svedman, et al.
Published: (2022-07-01) -
Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma
by: Ledong Sun, et al.
Published: (2019-04-01) -
Differences in expression profiles in malingant melanoma patients according to immunotherapy response
by: E. N. Lukyanova, et al.
Published: (2018-01-01) -
Cancer immunology and melanoma immunotherapy
by: Rudinei Diogo Marques Linck, et al.
Published: (2017-12-01)